Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the clinical efficacy and safety of Miglitol in patients with Type2 Diabetes Mellitus treated with Biguanide.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sanwa Kagaku Kenkyusho Co., Ltd.
• Treatments: Miglitol

Criteria

Inclusion Criteria:

• Type 2 diabetic patients treated with Biguanide

• Criteria for postprandial plasma glucose and HbA1c are met

Exclusion Criteria:

• Type 1 diabetes

• Patients treated with other antidiabetic drugs or Insulin